Discovery in mass tort cases operates through a coordinated federal process called multidistrict litigation (MDL), where hundreds or thousands of similar lawsuits are consolidated before a single judge to streamline the exchange of evidence. Rather than forcing each plaintiff to separately request the same corporate documents or depose the same witnesses, MDL discovery allows attorneys to share information across all cases””reducing costs, preventing contradictory rulings, and moving litigation forward more efficiently. For example, in the hair relaxer MDL currently pending in federal court, approximately 10,000 plaintiffs are benefiting from consolidated discovery that would be impossible to replicate individually. The discovery process in mass torts follows a carefully structured timeline that typically spans years rather than months.
Courts select a small group of representative cases, called bellwethers, to undergo intensive discovery first. These cases serve as test runs, helping both sides assess the strength of evidence and potential outcomes before thousands of other cases proceed. The Ozempic litigation illustrates this approach, with three bellwether trials scheduled for January, March, and May 2026 following extensive coordinated discovery. This article examines the specific discovery mechanisms used in mass tort litigation, including interrogatories, document requests, depositions, and expert testimony. It also covers how bellwether selection works, common compliance issues that arise, and the realistic timelines plaintiffs should expect when their case becomes part of an MDL.
Table of Contents
- What Discovery Methods Are Used in Mass Tort Litigation?
- How the Bellwether Process Shapes Mass Tort Discovery
- What Are Realistic Discovery Timelines in Major MDLs?
- Compliance Requirements and Discovery Sanctions
- The Role of Litigation Support in Mass Tort Discovery
- What Mass Tort Discovery Means for Case Outcomes
- Conclusion
What Discovery Methods Are Used in Mass Tort Litigation?
mass tort discovery employs the same fundamental tools as standard civil litigation, but at a dramatically larger scale. **Interrogatories**””written questions requiring answers under oath””allow plaintiffs to gather basic information about corporate defendants’ knowledge, testing procedures, and internal communications.
**Requests for production** compel both sides to turn over documents, which in mass torts often means millions of pages of corporate emails, internal memos, regulatory correspondence, and safety testing data. A single pharmaceutical defendant might produce terabytes of electronic records across years of product development and marketing.
- *Depositions** remain critical for establishing witness testimony before trial. In mass tort MDLs, attorneys depose key corporate executives, scientists, regulatory affairs personnel, and medical experts. These transcribed interviews serve dual purposes: they reveal what witnesses will say at trial, and they create a record that can impeach testimony if a witness later contradicts their sworn statements. The Uber sexual assault MDL (MDL 3084), which involves over 2,700 cases, has used depositions extensively to examine company policies and safety protocols.
- *Requests for admissions** streamline litigation by asking opposing parties to confirm or deny specific facts. If a defendant admits that a certain chemical compound was present in their product, for instance, plaintiffs don’t need to prove that point at trial. However, defendants rarely admit damaging facts voluntarily, which limits this tool’s practical impact in contentious mass tort litigation. The real evidence-gathering heavy lifting falls to document production and depositions.
How the Bellwether Process Shapes Mass Tort Discovery
Not every case in an MDL undergoes the same level of discovery. Courts select a subset of cases””typically between a dozen and several dozen””to serve as bellwethers. These representative cases receive focused, intensive discovery while the broader litigation waits. The hair relaxer MDL exemplifies this approach: after discovery concludes in February 2026, the court will narrow the pool to just 12 cases by March 2026 for potential trial. The bellwether selection process itself involves strategic considerations for both sides. Plaintiffs want cases with strong evidence and sympathetic facts. Defendants prefer cases with weaker causation evidence or complicating factors. Courts often allow each side to choose some cases while randomly selecting others to ensure a representative mix. In the Uber sexual assault litigation, the court organized 18 bellwether cases across five waves, with the first trial scheduled for January 7, 2026. However, bellwether outcomes don’t bind other cases. A plaintiff victory in a bellwether trial doesn’t guarantee success for others, and a defense verdict doesn’t doom remaining claims. The value lies in information: both sides learn how evidence plays before juries, which arguments resonate, and what damages might look like.
This information drives settlement negotiations for the thousands of cases waiting in the wings. If bellwether trials consistently favor plaintiffs, defendants face pressure to settle broadly rather than risk repeated losses. ## Expert Discovery and Daubert Challenges in Mass Torts Expert witnesses play an outsized role in mass tort litigation because these cases typically involve complex scientific and medical questions. Can a specific chemical cause cancer? Does a medical device fail at higher-than-expected rates? Did a pharmaceutical company know about risks it didn’t disclose? Answering these questions requires testimony from toxicologists, epidemiologists, medical specialists, and other experts. Expert discovery runs parallel to fact discovery but follows its own timeline. Experts prepare written reports explaining their opinions and methodology. Opposing counsel then deposes these experts, probing for weaknesses and inconsistencies. The Depo-Provera MDL has set a February 10, 2026 deadline for expert witness testimony disputes, illustrating how courts manage this specialized discovery track. Defendants frequently challenge plaintiff experts through **Daubert motions**, which ask the court to exclude testimony that doesn’t meet scientific reliability standards under Federal Rule of Evidence 702. If a court excludes a plaintiff’s causation expert, the case often cannot proceed””without expert testimony establishing that the defendant’s product caused the alleged harm, plaintiffs lack essential proof. These motions represent high-stakes battles that can effectively decide entire MDLs before any trial occurs. Plaintiffs must ensure their experts use methodologies that courts have previously accepted, with peer-reviewed research supporting their conclusions.
What Are Realistic Discovery Timelines in Major MDLs?
Mass tort discovery timelines stretch across years, not months. The largest MDL ever””the 3M military earplug litigation, which involved approximately 300,000 cases at its peak””took years to work through discovery and bellwether trials before reaching settlement. Plaintiffs entering current MDLs should understand that their individual cases won’t see discovery activity for extended periods. Current MDL timelines illustrate this reality. The paraquat herbicide litigation, with over 6,400 pending cases, has a bellwether trial set for October 14, 2025, with a second scheduled for April 6, 2026.
The Bard hernia mesh MDL contains over 24,000 cases as of April 2025 and continues working through discovery. The Covidien hernia mesh litigation, with approximately 1,863 cases, has jury selection for its first bellwether trial beginning February 17, 2026. These extended timelines create challenges for plaintiffs dealing with ongoing medical issues or financial hardship. However, consolidation makes litigation possible at all””individual plaintiffs could never afford to conduct independent discovery against well-funded corporate defendants. The tradeoff between efficiency and speed is inherent to the MDL structure. Cases that don’t settle after bellwether trials eventually return to their original courts for individual trials, though this rarely happens because the vast majority of MDL cases settle based on bellwether outcomes.
Compliance Requirements and Discovery Sanctions
Both sides in mass tort litigation face strict obligations to respond to discovery requests by court-established deadlines. Failure to comply can result in serious sanctions, including dismissal of claims, restrictions on what evidence parties can present, or even default judgment. Courts managing thousands of cases have limited patience for discovery abuse or delay tactics. For plaintiffs, compliance typically means producing medical records, employment records, and other documentation establishing their claims. Plaintiffs who fail to respond to legitimate discovery requests risk having their cases dismissed from the MDL.
For defendants, compliance involves searching for and producing relevant corporate documents””a process that can cost millions of dollars in e-discovery and document review expenses. Discovery disputes are common in mass torts, but courts generally resolve them quickly to keep litigation moving. Judges overseeing MDLs issue detailed case management orders specifying exactly what discovery is permitted, when responses are due, and how disputes should be raised. Parties who repeatedly violate these orders face escalating consequences. The sheer volume of cases creates pressure to follow procedures; judges cannot micromanage discovery disputes across thousands of individual matters.
The Role of Litigation Support in Mass Tort Discovery
The scale of mass tort discovery has spawned an entire industry of litigation support services. Law firms handling MDL cases routinely partner with vendors specializing in e-discovery, document review, medical record collection, and case management. These services prove essential when dealing with millions of documents and thousands of individual plaintiff files.
E-discovery platforms use technology-assisted review to identify relevant documents among vast corporate productions. Medical record analysis services organize and summarize treatment histories across plaintiff populations. Settlement administration firms track case inventories and manage distribution when cases resolve. For example, firms representing plaintiffs in the hair relaxer litigation must coordinate medical records, product purchase evidence, and other documentation across approximately 10,000 individual cases””a task impossible without systematic support infrastructure.
What Mass Tort Discovery Means for Case Outcomes
Discovery outcomes largely determine whether mass tort cases succeed or fail. The documents, testimony, and expert opinions gathered during this phase become the evidence presented at trial and the basis for settlement valuations. Strong discovery results””internal documents showing corporate knowledge of risks, expert testimony establishing causation, compelling plaintiff medical records””create leverage for favorable settlements. The bellwether trial system transforms discovery into a predictive tool.
When bellwether cases produce plaintiff verdicts or favorable settlements, the entire MDL gains value. When bellwethers fail, remaining cases face pressure to settle for less or risk dismissal. The Ozempic litigation, with three bellwether trials scheduled within five months of each other in 2026, will generate significant discovery-based information about how these cases perform before juries. Plaintiffs across the MDL will benefit or suffer based on outcomes they don’t directly control.
Conclusion
Discovery in mass tort cases operates through the MDL system’s consolidated approach, using standard litigation tools””interrogatories, document requests, depositions, and expert testimony””at an unprecedented scale. The bellwether process focuses intensive discovery on representative cases, generating information that shapes outcomes for thousands of plaintiffs. Current MDLs involving hair relaxers, GLP-1 medications, hernia mesh devices, and other products illustrate how this process unfolds over multi-year timelines with carefully managed deadlines and compliance requirements.
Plaintiffs entering mass tort litigation should understand that discovery is a collective process. Their individual cases contribute to and benefit from coordinated efforts across the MDL. While timelines are lengthy and individual control is limited, consolidation makes litigation viable against well-resourced corporate defendants. The discovery phase ultimately determines whether cases have sufficient evidence to succeed at trial or command meaningful settlement value.